My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de Osteoporosis y Metabolismo Mineral
On-line version ISSN 2173-2345Print version ISSN 1889-836X
Abstract
MORAN-LOPEZ, JM; CRESPO-GUTIERREZ, J and PUECH-DE ORIOL, M. Teriparatide in the substitutive treatment of chronic hypoparathyroidism. About a case. Rev Osteoporos Metab Miner [online]. 2022, vol.14, n.4, pp.104-106. Epub Mar 27, 2023. ISSN 2173-2345. https://dx.doi.org/10.4321/s1889-836x2022000400002.
Objetive:
To report experience in the use of teriparatide as an effective replacement therapy for chronic hypoparathy roidism.
Material and methods:
The clinical case of a patient with post‐surgical chronic hypoparathyroidism who previously presented difficult control with conventional treatment (calcium salts and calcitriol) is presented, for which teriparatide was started as a substitute treatment.
Results:
The patient presented analytical values of phosphocalcic metabolism compatible with normality from the 4th week of treatment with teriparatide, allowing the suspension of previous treatments and maintaining good control one year after the change in therapy.
Conclusions:
Teriparatide is an effective option for treating chronic hypoparathyroidism. We have observed a latency phase until the hormonal effect begins, so we recommend frequent analytical monitoring and gradually reduce treatment with calcitriol and calcium salts for adequate control.
Keywords : teriparatida; hipoparatiroidismo; crónico; postquirúrgico; tratamiento.